BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: de Freitas Júnior JR, Ribeiro IB, de Moura DTH, Sagae VMT, de Souza GMV, de Oliveira GHP, Sánchez-Luna SA, de Souza TF, de Moura ETH, de Oliveira CPMS, Bernardo WM, de Moura EGH. Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis. World J Hepatol 2021; 13(7): 815-829 [PMID: 34367502 DOI: 10.4254/wjh.v13.i7.815]
URL: https://www.wjgnet.com/1948-5182/full/v13/i7/815.htm
Number Citing Articles
1
Olufemi Aoko, Tobias Maharaj, Fiona Boland, Danny Cheriyan, John Ryan. Meta‐analysis: Impact of intragastric balloon therapy on NAFLD‐related parameters in patients with obesityAlimentary Pharmacology & Therapeutics 2024; 59(1): 8 doi: 10.1111/apt.17805
2
Khushboo Gala, Farah Abdul Razzak, Babusai Rapaka, Barham K. Abu Dayyeh. Novel Endoscopic Bariatric Therapies for the Management of Nonalcoholic SteatohepatitisSeminars in Liver Disease 2022; 42(04): 446 doi: 10.1055/a-1946-6285
3
Rahil H. Shah, Shyam Vedantam, Shria Kumar, Sunil Amin, Michelle Pearlman, Sean Bhalla. Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-AnalysisObesity Surgery 2023; 33(3): 725 doi: 10.1007/s11695-022-06437-7